Jan Aushadhi scheme has led to savings of Rs 7416 cr for citizens this fiscal: Govt

The projected sales target for 2023-24 is Rs 1,400 crore and the scheme is growing at a very fast pace garnering public trust and confidence, Khuba said.

Published On 2023-12-09 10:15 GMT   |   Update On 2023-12-13 12:24 GMT
Advertisement

New Delhi: The over 10,000 Jan Aushadhi Kendras across the country have led to savings of around Rs 7,416 crore for the citizens this financial year, Rajya Sabha was informed on Friday. In a written reply in the Upper House, Minister of State for Chemicals and Fertilisers Bhagwanth Khuba said an unprecedented 150 times growth in annual sales has been witnessed by the scheme in the last 9 years.

"During the financial year 2022-23, Pharmaceuticals & Medical Devices Bureau of India (PMBI) has sold Jan Aushadhi medicines worth Rs 1,236 crore, with approx 40 per cent growth from the previous year and this has led to savings of approximately Rs 7,416 crore to the citizens," he noted.
Advertisement
The projected sales target for 2023-24 is Rs 1,400 crore and the scheme is growing at a very fast pace garnering public trust and confidence, Khuba said.
In all, during the past nine years, total savings have been estimated at more than Rs 23,000 crore for the citizens under this scheme, he stated.
On an average 10-12 lakh people visit Jan Aushadhi Kendras (JAKs) daily, the minister said. Khuba stated that as of November 30 this year, 10,006 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) have been opened covering 753 districts across the country.
Replying to a separate question, Khuba said India's total import of active pharmaceutical ingredients (APIs) for 2022-23 is worth Rs 36,229.15 crore and the quantity is 4,02,111.18 metric tonnes.
Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News